BRANDON ROWLAND: Open Payments
NPI 1184946279 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 76 payments from 15 companies in 2025. Trend: 2023 $1,076 · 2024 $1,733 · 2025 $1,760
Food & beverage: $1,575Education: $185
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $395 |
| Regeneron Healthcare Solutions, Inc. | 12 | $385 |
| Janssen Biotech, Inc. | 7 | $178 |
| Novartis Pharmaceuticals Corporation | 6 | $173 |
| ABBVIE INC. | 11 | $157 |
| Lilly USA, LLC | 3 | $86 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Organon LLC | 2 | $66 |
| Galderma Laboratories, L.P. | 3 | $64 |
| PFIZER INC. | 3 | $63 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, TALTZ, Sotyktu, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
